Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Acrivon Therapeutics, Inc. Common Stock
ACRVCurrent price
7.92 USD
-0.03 USD (-0.38%)
Last closed
7.93 USD
Company
www.acrivon.com
ISIN
US0048901096
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
265 431 744 USD
Yield for 12 month
+52.60 %
1Y
3Y
5Y
10Y
15Y
ACRV
Acrivon Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in developing oncology medicines for the patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient responder identification platform. The company's Acrivon Predictive Precision Proteomics, a precision medicine platform enables the creation of drug specific proprietary OncoSignature companion diagnostics that are used to identify the patients to benefit from its drug candidates. Its lead clinical candidate is ACR-368, a selective small molecule inhibitor targeting CHK1 and CHK2, which is in Phase II clinical trial across various tumor types, including platinum-resistant ovarian, endometrial, and bladder cancer. The company is also developing its preclinical stage pipeline programs targeting critical nodes in the DNA damage response, or DDR, pathways; and ACR-2316, a dual WEE1/PKMYT1 inhibitor. Acrivon Therapeutics, Inc. was incorporated in 2018 and is based in Watertown, Massachusetts. Address: 480 Arsenal Way, Watertown, MA, United States, 02472
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
21.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-536 000 USD
Last Year
-1 095 000 USD
Current Quarter
-200 000 USD
Last Quarter
-224 000 USD
Key Figures ACRV
1 year
3 years
5 years
10 years
EBITDA
-75 561 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.41 %
PEG Ratio
–
Return On Equity TTM
-37.78 %
Wall Street Target Price
21.67 USD
Revenue TTM
–
Book Value
6.98 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-2.72 USD
Diluted Eps TTM
-2.72 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ACRV
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History ACRV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ACRV
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
-0.4267
Price Book MRQ
1.2249
Financials ACRV
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ACRV
For 52 weeks
3.19 USD
11.9 USD
50 Day MA
7.84 USD
Shares Short Prior Month
1 207 265
200 Day MA
7.21 USD
Short Ratio
7.93
Shares Short
1 112 309
Short Percent
9.43 %
BeatStart